EFPIA

EFPIA created "Partners in Research" as a constituent entity open to companies operating in associated sectors (such as imaging, MedTech, diagnostics, animal health, IT - including e- and m-technologies, contract research organisations, etc.), and aiming to participate to collaborative research partnerships. This membership status made it possible to jointly design and implement collaborative R&D initiatives in the framework of the Innovative Medicines Initiative (IMI), which implemented new R&D, operational, and business models that benefit all sectors involved (impact on R&D processes), patients (new treatment pathways), and society (incentives for reinvestment in areas where there is market failure)... The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe. Through its direct membership of 37 national associations, 40 leading pharmaceutical companies and a growing number of small and medium-sized..

Also known as: EFPIA Japan

Primary location: Brussels United States